{
  "denotations": [
    {
      "id": "T1",
      "obj": "Disease",
      "span": {
        "begin": 31,
        "end": 49
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 92,
        "end": 101
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 132,
        "end": 142
      }
    },
    {
      "id": "T7",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 157,
        "end": 166
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 111,
        "end": 131
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "25143362_5",
  "text": "We treated three patients with muscular dystrophy due to a homozygous Arg555Trp mutation in dysferlin with the proteasome inhibitor bortezomib and monitored dysferlin expression in monocytes and in skeletal muscle by repeated percutaneous muscle biopsy ."
}
